Conecte-se

Bibliografias temáticas / Cerebrovascular disease - Patients

Índice

Artigos de revistas
Teses / dissertações
Livros
Capítulos de livros
Trabalhos de conferências
Relatórios de organizações

Literatura científica selecionada sobre o tema "Cerebrovascular disease - Patients"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 31 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Cerebrovascular disease - Patients".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Artigos de revistas sobre o assunto "Cerebrovascular disease - Patients"

1

Rotta, Newra Tellechea, Alexandre Rodrigues da Silva, Flora Luciana Figueira da Silva, Lygia Ohlweiler, Eraldo Belarmino Jr, Valéria Raimundo Fonteles, Josiane Ranzan, Orlando Javier Ramos Rodriguez e Régis Osório Martins. "Cerebrovascular disease in pediatric patients". Arquivos de Neuro-Psiquiatria 60, n.º 4 (dezembro de 2002): 959–63. http://dx.doi.org/10.1590/s0004-282x2002000600013.

Texto completo da fonte

Resumo:

Although rare in childhood, stroke may have a serious impact when it happens in this stage of life. Also, it may be the first sign of a systemic disease. We report 12 cases of patients with stroke treated in the Neuropediatrics Unit of Hospital de Clínicas de Porto Alegre (HCPA) from March 1997 to March 2000. All patients, from term infants to 12-year-old children hospitalized in the Pediatrics Unit of HCPA, had clinical suspicion of stroke, which was later confirmed by radiological studies. Patient follow up ranged from 1 to 6 years (mean = 3.4 years). Presenting symptoms were hemiparesis in 9 patients, seizures in 7, deviation of labial commissure in 3, and loss of consciousness in 1. The increase in the number of cases of childhood stroke identified and later confirmed by noninvasive methods had helped in the determination of different ethiologies of stroke: the most frequent being hematologic, cardiac and genetic diseases. However, our study included 6 newborns with stroke whose ethiology was not identified. Seven children with seizures received phenobarbital. Six term infants had neonatal seizures secondary to stroke and restricted to the first 72 hours of life.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Grotta, James. "Cerebrovascular Disease in Young Patients". Thrombosis and Haemostasis 78, n.º 01 (1997): 013–23. http://dx.doi.org/10.1055/s-0038-1657494.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Mirkhamzaevna, Mamurova Malika, e Abrorova Viloyathon. "INTRODUCTION OF PATIENTS WITH CHRONIC CEREBROVASCULAR DISEASE CAUSED BY ARTERIAL HYPOTENSION, IN PATIENTS OF YOUNG AGE". Frontline Medical Sciences and Pharmaceutical Journal 02, n.º 04 (1 de abril de 2022): 47–52. http://dx.doi.org/10.37547/medical-fmspj-02-04-07.

Texto completo da fonte

Resumo:

Vascular diseases of the brain due to their high prevalence and severe consequences for the health of the population represent a major medical and social problem. In the structure of cerebrovascular diseases significant weight have chronic forms of vascular lesions of the brain, which in the domestic literature is traditionally treated as a discirculatory encephalopathy. In Uzbekistan the number of sufferers with chronic forms of cerebrovascular diseases is increasing, therefore the urgency of solving this problem in Uzbekistan can be defined as an extreme one, requiring the concentration of efforts of specialists in different fields.

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Parfenov, V. A. "Ménière’s disease and chronic cerebrovascular diseases". Meditsinskiy sovet = Medical Council, n.º 19 (1 de dezembro de 2021): 35–40. http://dx.doi.org/10.21518/2079-701x-2021-19-35-40.

Texto completo da fonte

Resumo:

Ménière’s disease (MD) is an idiopathic inner ear disease, which is characterized by noise in the ears, periodic attacks of vertigo and the development of sensorineural hearing loss. MD is characterized by endolymphatic hydrops – an increase in the volume of endolymph that fills the membered labyrinth of the inner ear. Currently highlighted subtypes MD. The first subtype meets most often and is characterized by classical manifestations of MD. The second subtype is characterized by the development of sensorineural hearing loss, to which only after a long time are joined by the episodes of dizziness. The third subtype of MD includes family cases of the disease. The fourth and fifth subtypes of MD is observed in patients with migraine and autoimmune diseases. The diagnosis of definite MD is based on the 2 or more spontaneous episodes of vertigo with each lasting 20 minutes to 12 hours, low-to medium-frequency sensorineural hearing loss in one ear, fluctuating aural symptoms (fullness, hearing, tinnitus) located in the affected ear, and lack of data for other reasons for dizziness. There are no effective treatment for auditory disorders MD, therapy is aimed at preventing dizziness attacks. The first line of MD’s therapy includes a dietary salt restriction, the use of betahistine and diuretics. Betahistine (Betaserc) is usually used in a daily dose of 48 mg for 3–6 months to reduce the frequency of vertigo. For long-term treatment, it is convenient to use a betahistine modified-released (Betaserc Long) 48 mg, taken once a day. With the ineffectiveness of conservative therapy, other methods of therapy are possible: intratympanic administration of corticosteroids or gentamicin, labyrinthectomy or vestibular neurectomy. Unfortunately, many patients suffering from BM mistakenly makes a diagnosis of cerebrovascular disease, vertebrobasilar insufficiency, cervical osteochondrosis. Diagnostic errors are usually caused by the fact that the patients with MD are not conducted audiometry, vestibular tests, and the signs of cerebral microangiopathy identified when MRI brain are mistakenly regarded as confirmation of vascular dizziness genesis.

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Starchina, Yu A., O. V. Kosivtsova e E. A. Sokolov. "Management of patients with chronic cerebrovascular disease". Neurology, Neuropsychiatry, Psychosomatics 15, n.º 2 (30 de abril de 2023): 91–97. http://dx.doi.org/10.14412/2074-2711-2023-2-91-97.

Texto completo da fonte

Resumo:

Cerebrovascular disease is one of the most common pathologies in the practice of a neurologist. Vascular cognitive impairment is the earliest and most objective sign of cerebrovascular pathology. The correction of vascular risk factors – antihypertensive, antiplatelet, lipid-lowering therapy, have the leading role in the treatment of patients with cerebrovascular diseases. It is necessary to pay special attention to non-drug methods of therapy, such as quitting smoking and alcohol abuse, regular physical activity. The possibilities of using dipyridamole for symptomatic and pathogenetic therapy are discussed.

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Kitamura, Shin. "Neuroimaging in patients with cerebrovascular disease". Journal of Nippon Medical School 61, n.º 5 (1994): 510–11. http://dx.doi.org/10.1272/jnms1923.61.510.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Khasanova, D. R., T. V. Danilova e Z. K. Latypova. "Epilepsy in patients with ischemic brain disease". Kazan medical journal 94, n.º 2 (15 de abril de 2013): 235–39. http://dx.doi.org/10.17816/kmj1595.

Texto completo da fonte

Resumo:

Epilepsy is one of the most actual social problems in modern neurology and psychiatry. According to the results of the domestic and foreign studies, the risk of developing epilepsy increases with age. The increased rate of nervous system vascular and degenerative diseases as well as brain tumors and head injuries in elderly patients is one of the reasons for it. The review is devoted to the development of epilepsy in adults having an active cerebrovascular disease. Epilepsy is the disease with multiple causative factors. Among the etiological factors of epilepsy development in adults, the predominant place belongs to vascular diseases. The article presents the epidemiological aspects of the problem, the questions of pathophysiology, the variability of epileptic syndromes developing as a result of ischemic brain disease. It describes the characteristics of epileptic process as a result of a vascular lesion. The role of the cerebrovascular reactivity in brain vascular diseases development is described. A place of different research methods (such as electroencephalography, transcranial and extracranial duplex ultrasonography scanning of the major brain vessels, different modes of magnetic resonance imaging, functional magnetic resonance imaging and magnetic resonance spectroscopy) in identifying risk factors for seizures in patients with cerebrovascular pathology is reported. Possible exogenous and endogenous precipitants (cerebral atherosclerotic vascular disease, hypertension, cerebrovascular deregulation, increased convulsive predisposition, the external epileptic triggers, etc.) are described.

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Locāne, Sintija, Elīna Pūcīte, Evija Miglāne, Andrejs Millers, Arina Novasa, Renija Ieviņa e Tatjana Muravska. "Antiplatelet Resistance in Patients with Atherosclerosis". Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 73, n.º 4 (1 de agosto de 2019): 373–78. http://dx.doi.org/10.2478/prolas-2019-0058.

Texto completo da fonte

Resumo:

Abstract Variable platelet response to aspirin and clopidogrel is a well-known phenomenon in patients with coronary artery disease and ischemic cerebral stroke. The objective of the present study was to evaluate the frequency and possible risk factors of antiplatelet resistance in patients with cerebrovascular and cardiovascular diseases. The VerifyNow system was used to evaluate adenosine-5-diphosphate and platelet P2YI2 receptor function in patients with cerebrovascular and cardiovascular disease, who received dual antiplatelet therapy. Aspirin resistance was defined as aspirin reaction units (ARU) ≥ 550. Clopidogrel resistance was defined as Platelet Reaction Units (PRU) > 230. In the group of cerebrovascular diseases there were 13.2% (n = 27) patients with aspirin and 24.5% (n = 50) with clopidogrel resistance. However, in the cardiovascular group there were 20% (n = 9) aspirin and 11.1% (n = 5) clopidogrel resistant patients. In the cerebrovascular group, aspirin resistant patients had a lower triglyceride level (p = 0.001, r = 0.26) than aspirin sensitive patients. Clopidogrel resistant patients had a significantly higher level of glycated haemoglobin (HbA1C) (p = 0.016, r = 023), triglycerides (p = 0.033, r = 0.16) and lower level of high-density lipoproteins (p = 0.027, r = 0.16) than clopidogrel sensitive patients. In the cardiovascular group, patients who were resistant to aspirin had a significantly higher high-density lipoprotein level (p = 0.038, r = 0.31). No other factors differed significantly between the aspirin or clopidogrel resistant and sensitive patients in the cardiovascular group. Aspirin resistance was more common in patients with cardiovascular disease, and clopidogrel resistance in patients with cerebrovascular disease, although the difference was not significant. Our findings indicate that diabetes mellitus and an elevated level of lipoproteins could be risk factors for aspirin or clopidogrel resistance in patients with cerebrovascular diseases. Further studies should be conducted using larger patient cohorts with balanced groups of patients to investigate clinical aspects of antiplatelet resistance.

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Martinez, Veline, Esteban Echeverri, Maria Alejandra Urbano, Laura Juliana Ballen e Guillermo Edinson Guzman. "Hemorrhagic Cerebrovascular Disease". Revista Ciencias de la Salud 21, n.º 3 (4 de outubro de 2023): 1–12. http://dx.doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.12671.

Texto completo da fonte

Resumo:

Introduction: Stroke is a major cause of morbidity and mortality worldwide, with hemorrhagic stroke being the deadliest form of acute stroke. Therefore, the cause of the event should be determined to direct the associated therapy and take preventive measures. Hyperhomocysteinemia has been described as a rare etiology of stroke. Although hyperhomocysteinemia has been associated with venous thrombotic events, altered endothelial function, and procoagulant states, its clinical role in stroke remains controversial. Case description: We present a case of a 60-year-old male patient with primary autoimmune hypothyroidism who presented with dysarthria, facial paresis, and left upper-limb monoparesis after sexual intercourse. A simple skull computed tomography scan showed hyperintensity in the right basal ganglion, indicating an acute hemorrhagic event. Etiological studies were performed, including ambulatory blood pressure monitoring, cerebral angiography, and transthoracic echocardiogram, which ruled out underlying vascular pathology. During follow-up, vitamin B12 deficiency and hyperhomocysteinemia were detected, without other blood biochemical profile alterations. Supplementation was initiated, and homocysteine levels gradually decreased, without new neurological deficits observed during follow-up. Conclusion: Quantification of homocysteine should be considered in patients with a cerebrovascular disease without apparent cause, as documenting hyperhomocysteinemia and correcting its underlying etiology are essential not only for providing appropriate management but also for preventing future events.

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

LABINSKIY, A. "Ultramicroscopic study of hair follicles in healthy people and patients with cerebrovascular disease". Experimental and Clinical Physiology and Biochemistry 2015, n.º 3 (15 de setembro de 2015): 37–40. http://dx.doi.org/10.25040/ecpb2015.03.037.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Mais fontes

Teses / dissertações sobre o assunto "Cerebrovascular disease - Patients"

1

Hoffmann, Tammy Coral. "Development and evaluation of a computer-generated individualised written education package for patients following stroke and their carers /". [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18924.pdf.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Ellis, Graham. "Stroke liaison workers for patients and carers". Thesis, Connect to e-thesis, 2008. http://theses.gla.ac.uk/288/.

Texto completo da fonte

Resumo:

Thesis (MD.) - University of Glasgow, 2007.
MD. thesis submitted to the Division of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, 2007. Includes bibliographical references. Print version also available.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Kwok, Wing-yee Eunice. "Early supported discharge program for stroke patients". Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B40720883.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Vattanasilp, Wantana. "The contribution of neural and peripheral factors to muscle stiffness and function following stroke". Thesis, The University of Sydney, 1998. https://hdl.handle.net/2123/26242.

Texto completo da fonte

Resumo:

The aim of these studies was to investigate the contributions of neural and peripheral factors to the increased resistance to movement and loss of function commonly observed following stroke. Three studies were undertaken to investigate the stiffness of the calf muscles in stroke subjects. Under relaxed conditions, neural factors such as spasticity and peripheral factors such as contracture and thixotropy were investigated. Under active conditions, the contribution of the tonic stretch reﬂex to functional movement, in this case walking, was investigated. These ﬁndings were compared to results retained from neurologically-normal subjects. The clinical measurements of spasticity (Ashworth Scale and tendon jerk) were collected and the laboratory measurement (tonic stretch reﬂex) was measured in all studies. Clinical measurements of spasticity were performed to describe the stroke subjects clinically, whereas the laboratory measurement, ie, the measurement of the tonic stretch reﬂex recording EMG during sinusoidal stretching, was performed to provide a quantitative benchmark of spasticity in the gastrocnemius muscle. Measurement of the tonic stretch reﬂex was chosen because EMG can differentiate the neural and the peripheral contributions. Under relaxed conditions, it was found that most stroke subjects exhibited resting tonic stretch reﬂexes, indicating the presence of spasticity. Stroke subjects also exhibited a thixotropic response which was within the range of normal responses. Some stroke subjects displayed muscle contracture. When the contributions of these various factors to stiffness were examined, contracture appeared to make the most significant contribution to the increased resistance to movement. Under active conditions, the contribution of spasticity to walking dysfunction following stroke was investigated in a group of ambulant stroke subjects. The tonic stretch reﬂex was investigated under active conditions which mimicked the movement of the ankle joint during walking. Stroke subjects exhibited a smaller action tonic stretch reﬂex compared with normal subjects, and this ﬁnding was not statistically different. It was suggested that rather than exhibiting an ‘out of control’ tonic stretch reﬂex, stroke subjects had an impaired modulation of the tonic stretch reﬂex. Also, the action tonic stretch reﬂex of stroke subjects did not contribute as much as that of normal subjects to the resistance of calf muscles under active conditions. Therefore, it is suggested that an abnormal tonic stretch reﬂex does not routinely contribute to walking dysfunction following stroke. Furthermore, when the modulation of the tonic stretch reﬂex was measured at pre-ambulatory and ambulatory stages after early stroke, it was found that an improvement in function of the ankle joint was not accompanied by an ability to modulate the tonic stretch reﬂex in the gastrocnemius muscle. Finally, a relation between the clinical and laboratory measurements of spasticity was found only for the tests of resistance to movement, but not for the tests of reﬂex activity. These ﬁndings suggested that clinical tests cannot adequately quantify spasticity, and that the resistance felt during passive movement cannot be differentiated using a clinical grading test such as the Ashworth Scale. These studies add to the growing body of evidence that spasticity is not the major problem interfering with functional tasks after stroke. Therefore, it is not important to routinely reduce spasticity for the purpose of improvement in function. However, the need to prevent and/or minimise muscle contracture is essential in order to avoid the increase in passive stiffness which accompanies the contracture.

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Willats, Lisa. "Improved quantification of perfusion in patients with cerebrovascular disease". Thesis, University College London (University of London), 2008. http://discovery.ucl.ac.uk/1445148/.

Texto completo da fonte

Resumo:

In recent years measurements of cerebral perfusion using bolus-tracking MRI have become common clinical practice in the diagnosis and management of patients with stroke and cerebrovascular disease. An active area of research is the development of methods to identify brain tissue that is at risk of irreversible damage, but amenable to salvage using reperfusion treatments, such as thrombolysis. However, the specificity and sensitivity of these methods are limited by the inaccuracies in the perfusion data. Accurate measurements of perfusion are difficult to obtain, especially in patients with cerebrovascular diseases. In particular, if the bolus of MR contrast is delayed and/or dispersed due to cerebral arterial abnormalities, perfusion is likely to be underestimated using the standard analysis techniques. The potential for such underestimation is often overlooked when using the perfusion maps to assess stroke patients. Since thrombolysis can increase the risk of haemorrhage, a misidentification of 'at-risk' tissue has potentially dangerous clinical implications. This thesis presents several methodologies which aim to improve the accuracy and interpretation of the analysed bolus-tracking data. Two novel data analysis techniques are proposed, which enable the identification of brain regions where delay and dispersion of the bolus are likely to bias the perfusion measurements. In this way true hypoperfusion can be distinguished from erroneously low perfusion estimates. The size of the perfusion measurement errors are investigated in vivo, and a parameterised characterisation of the bolus delay and dispersion is obtained. Such information is valuable for the interpretation of in vivo data, and for further investigation into the effects of abnormal vasculature on perfusion estimates. Finally, methodology is presented to minimise the perfusion measurement errors prevalent in patients with cerebrovascular diseases. The in vivo application of this method highlights the dangers of interpreting perfusion values independently of the bolus delay and dispersion.

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Rau, Marie Therese. "Elderly stroke patients and their partners: a longitudinal study of social support and well-being changes associated with a disabling stroke". PDXScholar, 1986. https://pdxscholar.library.pdx.edu/open_access_etds/478.

Texto completo da fonte

Resumo:

This investigation explored the relationship of demographic, social network, social support, and stroke-related factors to depressive symptomatology and well-being in 50 elderly individuals who had recently suffered a first, completed stroke and their partners. Data were gathered at two points in time, with interviews scheduled six months apart. Outcome measures included the CES-D depression scale and the Index of Psychological Well-Being. Data were analyzed using descriptive statistics, correlational procedures, multiple regression, and change-focused regression analyses. For the caregivers, lower depression levels at Time 1 were associated with better subjective health, less concern about being able to care for the patient in the future, higher levels of patient ADL functioning, greater perceived pre-stroke instrumental support, and greater patient optimism. At Time 2, lower caregiver depression scores were associated with lower levels of perceived burden, fewer health problems or negative changes in health status, fewer negative network interactions, greater network density, greater frequency of network contacts, and fewer perceived personality and behavior changes in the patient. Best predictors of depression score for the caregivers at Time 1 were subjective health rating, the patient's level of ADL functioning, degree of concern about ability to care for the patient in the future, the proportion of the network providing instrumental support, and the percent of reciprocal confiding relationships reported. At Time 2, best predictors of depression were level of perceived caregiver burden, objective health score, and network density. The best predictor of caregiver depression level over time was Time 1 depression level. Perceived caregiver burden was also a strong predictor of depression score. For the patients, higher depression scores at Time 1 were associated with whether they felt they could have done anything to prevent the stroke, higher levels of concern about their partner's ability to care for them in the future, and greater reported frequency of pre-stroke disagreement with their partners. At Time 2, higher levels of depressive symptomatology were associated with decreased satisfaction with amount of social contact, a greater proportion of friends in the post-stroke network, a greater degree of perceived negative health change, and change in employment status.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

張晶凝 e Ching-ying Crystal Cheung. "Facial emotion recognition after subcortical cerebrovascular diseases". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31224155.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Wan, Wai-kuen Christina, e 尹慧娟. "An exploratory design of an empowerment group for the strokesurvivors". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1996. http://hub.hku.hk/bib/B31978228.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Cotter, Paul Eoin. "Cardiac parameters in young patients with cryptogenic stroke". Thesis, University of Cambridge, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.648802.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Sit, Bik-yan Sonia. "Cognitive function in Chinese stroke patients /". View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31595923.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Mais fontes

Livros sobre o assunto "Cerebrovascular disease - Patients"

1

Wallace, Sife, ed. After stroke: Enhancing quality of life. New York: Haworth Press, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

N, Di Lima Sara, e Aspen Reference Group (Aspen Publishers), eds. Stroke rehabilitation: Patient education manual. Gaithersburg, Md: Aspen Publishers, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Bredow, Hasso von. In the blink of an eye. London: Orion, 2010.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Lee, Mathew H. M., 1931-, Bell Harriet e Howard A. Rusk Institute of Rehabilitation Medicine., eds. Reco vering at home after a stroke: A practical guide for you and your family. New York: Body Press/Perigee, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Kelson, Marcia. Care after stroke: Information for patients and their carers : based on the national clinical guidelines for stroke. London: Royal College of Physicians, 2000.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Cardiovascular Disease and Stroke Prevention Program (Colo.), ed. Survivors of the fight: Stroke in Colorado : a report to the Colorado Legislature from the Colorado Stroke Advisory Board. 2^a ed. Denver, Colo: Colorado Dept. of Public Health and Environment, Cardiovascular Disease and Stroke Prevention Program, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Youngson, R. M. Stroke!: A self-help manual for stroke sufferers and their relatives. Newton Abbot: David & Charles, 1987.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Senelick, Richard C. Living with stroke: A guide for families : help and new hope for all those touched by stroke. Lincolnwood, Ill: Contemporary Books, 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Senelick, Richard C. Living with stroke: A guide for families. Birmingham, Ala: HealthSouth Press, 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Senelick, Richard C. Living with stroke: A guide for families. Chicago: Contemporary Books, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Mais fontes

Capítulos de livros sobre o assunto "Cerebrovascular disease - Patients"

1

Setacci, Carlo, Maria Agnese Mele, Giuseppe Galzerano, Giuseppe de Donato, Domenico Benevento, Massimiliano Walter Guerrieri, Francesco Setacci e Bruno Amato. "Cerebrovascular Disease and Critical Limb Ischaemia". In Surgical Management of Elderly Patients, 257–70. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-60861-7_16.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Moulignier, A. "Cerebrovascular Disease in HIV-Infected Patients". In Cardiovascular Disease in AIDS, 131–45. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1_10.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Zimmerman, Robert D., Norman E. Leeds e Mark J. Goldman. "Digital Subtraction Angiography in the Evaluation of Patients with Cerebrovascular Disease". In Cerebrovascular Surgery, 343–58. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4612-5032-6_2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Tarabishy, Abdul R., Maurice M. Miller e Ansaar T. Rai. "Counseling and Management of Patients with Intracranial Atherosclerosis Disease". In Management of Cerebrovascular Disorders, 445–57. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99016-3_29.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Yu, Yannan, e David Yen-Ting Chen. "Machine Learning for Cerebrovascular Disorders". In Machine Learning for Brain Disorders, 921–61. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-3195-9_29.

Texto completo da fonte

Resumo:

AbstractCerebrovascular disease refers to a group of conditions that affect blood flow and the blood vessels in the brain. It is one of the leading causes of mortality and disability worldwide, imposing a significant socioeconomic burden to society. Research on cerebrovascular diseases has been rapidly progressing leading to improvement in the diagnosis and management of patients nowadays. Machine learning holds many promises for further improving clinical care of these disorders. In this chapter, we will briefly introduce general information regarding cerebrovascular disorders and summarize some of the most promising fields in which machine learning shall be valuable to improve research and patient care. More specifically, we will cover the following cerebrovascular disorders: stroke (both ischemic and hemorrhagic), cerebral microbleeds, cerebral vascular malformations, intracranial aneurysms, and cerebral small vessel disease (white matter hyperintensities, lacunes, perivascular spaces).

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Hobbs, R. E., e A. J. Furlan. "Detection of Coronary Artery Disease in Patients with Cerebrovascular Disease". In Clinical Medicine and the Nervous System, 357–73. London: Springer London, 1987. http://dx.doi.org/10.1007/978-1-4471-3129-8_19.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Piepgras, A., P. Schmiedek, G. Leinsinger, R. L. Haberl, C. M. Kirsch e K. M. Einhäupl. "Follow-up Studies of Cerebrovascular Reserve Capacity in Patients with Cerebrovascular Disease". In Stimulated Cerebral Blood Flow, 263–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77102-6_29.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

van Niftrik, Christiaan Hendrik Bas, Martina Sebök, Giovanni Muscas, Aimée Hiller, Matthias Halter, Susanne Wegener, Luca Regli e Jorn Fierstra. "Hemodynamic Evaluation of Paradoxical Blood Oxygenation Level-Dependent Cerebrovascular with Transcranial and MR Perfusion in Patients with Symptomatic Cerebrovascular Steno-occlusive Disease". In Cerebrovascular Reactivity, 89–101. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1763-2_6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Díez-Villanueva, Pablo, e Manuel Martínez-Sellés. "End-of-Life Care in Hospitalized Patients with Cardiovascular and Cerebrovascular Disease". In End-of-Life Care in Cardiovascular Disease, 51–69. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6521-7_4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Savino, Peter J. "Risk of Cerebrovascular Disease in Patients with Anterior Ischemic Optic Neuropathy". In Amaurosis Fugax, 114–17. New York, NY: Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3776-1_9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Trabalhos de conferências sobre o assunto "Cerebrovascular disease - Patients"

1

Gramasco, Hendrick Henrique Fernandes, Mateus Felipe dos Santos, Yasmim Nadime José Frigo, Guilherme Drumond Jardini Anastácio, Stella de Angelis Trivellato, Daniel Fabiano Barbosa dos Santos, Ana Cláudia Pires Carvalho et al. "Diverse clinical presentations of Moyamoya disease: a case series". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.530.

Texto completo da fonte

Resumo:

Context: Moyamoya disease or chronic occlusive cerebrovascular disease is characterized by proximal occlusion of the internal carotid artery and its branches bilaterally, generating an angiographic “smoke” pattern (moyamoya, from Japanese “something hazy”) and by diverse ischemic manifestations. Case report: The sample consists of three female patients, aged between 13 and 46 years, followed in our service due to the diagnosis of Moyamoya Disease. Among the clinical manifestations presented, ischemic cerebrovascular events with neurological deficit predominated, and one of the patients presented two episodes compatible with stroke and one episode compatible with transient ischemic accident. The youngest patient presented with a choreic picture initially interpreted as Sydenham’s chorea. Although the gold standard for the diagnosis of chronic occlusive cerebrovascular disease is cerebral arterial angiography, it was possible to observe a pattern compatible with the disease in other modalities of examination, such as cerebral arterial angiotomography and cerebral arterial angioresonance. From the therapeutic point of view, one of the patients underwent surgical intervention (encephaloduromyosinangiosis), with improvement of symptoms after treatment. Conclusions: In this paper, we emphasize the importance of complementary imaging tests in the evaluation of patients with cerebrovascular syndromes and the diversity of clinical presentation of Moyamoya disease.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Martins, Karine Felipe, Flávia Pascoal Teles, Amanda Fernandes de Sousa Oliveira Balestra e Isadora Rosa Maia. "Cerebrovascular diseases: the importance of recognizing them". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.188.

Texto completo da fonte

Resumo:

Background: Until the 70s, cerebrovascular diseases (CVDs) were neglected to the lack of resources. However, due to the advancement of technology, several imaging tests have appeared, such as magnetic resonance and computed tomography, which facilitated the diagnosis and the understanding of the pathophysiology of each disease. Objectives: The objective of this work is to identify the main CVDs signs and symptoms. Methods: An integrative literature review was carried out based on selected articles from Google Scholar, PubMed and SciELO, using the terms headache, cerebrovascular disease, neurology. Results: CVDs are characterized by causing damage to brain vessels, due to changes in blood flow momentarily or permanently in an area of the brain, allowing them to be classified as ischemic or hemorrhagic. In ischemic there is a blockage of blood flow and, consequently, of oxygen to areas of the brain, in hemorrhagic rupture of a vessel occurs and, with this, blood leakage. Therefore, it is necessary to recognize the signs and symptoms early, in order to prevent loss of neurological function, movements on one side of the body and the presence or absence of headaches in both patients, with ischemic CVD and hemorrhagic CVD prevent rapid loss of consciousness accompanied by severe headache. Such signs and symptoms associated with the patient’s family history and lifestyle can help in the diagnosis of this disease. Conclusion: Therefore, it is important to recognize the signs and symptoms of CVDs, in order to determine the treatment and advise the patient, which will guarantee a better prognosis.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Maltri, Rebecca, Fernanda Peronti Marino, Jorge Ygor Gonçalves dos Santos, Nathalia Polliana Rodrigues Melgaço, Vitória Aparecida Cunha, Paola Falcão Moreira Nogueira, Rafaela Charles Correia e Tiago Silva Carvalho. "Brain stroke in patients with Covid-19 disease". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.625.

Texto completo da fonte

Resumo:

Background: Currently, the world is facing a pandemic caused by the SARSCoV-2, which has already infected millions of people and has accumulated countless deaths. Association has been reported between severe conditions of this disease and the occurrence of neurological manifestations, including stroke. The mechanisms that trigger this cerebrovascular disease in infected people are not defined yet, but it’s believed that they involve inflammatory reaction, vascular endothelial dysfunction and hypercoagulopathy present in SARS-CoV-2 infection. Objectives: Verify the studies which relate the cerebrovascular disorders caused by the infection of SARS-CoV-2, in order to elucidate its performance and determine the patient’s management as a way to avoid outcomes such as stroke and other neurological conditions losses. Methods: The subject is approached through a narrative review of the literature without meta-analysis. A bibliographic survey was made out, from December 2019 to June 2020, in digital databases. Results: The relation between ischemic and hemorrhagic strokes with coronavirus infection shows a possible mechanism of action of the virus related to ACE2, damaging tissues, including the brain. In addition, a huge relation has been identified between coagulopathy induced by the infectious condition and the occurrence of stroke, since the intense inflammatory storm produced raises the risks of occurrence of cerebrovascular events. Conclusions: The activity of this coronavirus against ACE2 has been shown to increase the secretion of pro-inflammatory substances, causing brain damage. Although this is a new disease, it’s possible to establish the stroke as a complication of COVID-19. It should be considered, especially in critically ill patients, and promptly assisted.

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Oliveira, Francisco Gabriel Cabral, Juliana Paiva Ribeiro Moura, Matheus Henrique Oliveira e Mylena Teles de Jesus. "The relation between COVID-19 and cerebrovascular diseases". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.740.

Texto completo da fonte

Resumo:

Introduction: Covid-19 is characterized by respiratory syndrome and has symptoms that affect the central nervous system such as headache, anosmia, hypercoagulability, etc. In this sense, it is known that the virus shows tropism by the receptors of the angiotensin-converting enzyme 2 (ACE2), becoming a gateway to the neurological system, which can cause complications. Is to relate the infection by COVID-19 and the increase in cerebrovascular diseases. Methods: A literature review was carried out using search for scientific articles in PubMed, in April / 2021, with a filter in the last 5 years, using the descriptors “Covid”, “Cerebrovascular Diseases” and “Man” associated with the Boolean operator AND. Results: 53 articles were found, of which 19 were selected for research. There is a higher frequency of neurological symptoms in patients with COVID-19 than in patients without the disease. The effect of binding the virus to ACE2 receptors is to activate a cascade of cytokines, which tends to lead to serious complications. For this reason, severe coagulopathies can be caused, increasing products of the degradation of C-reactive protein, D Dimer, fibrinogen and thrombocytopenia. The increase in cerebrovascular events also occurs because the antithrombotic, neuroprotective, antihypertensive effects, among others, of the alternative renin-angiotensin system in the brain are interrupted due to COVID-19. Conclusion: It was seen that cerebrovascular events are related to the course of COVID-19, in which patients may develop several serious complications, such as encephalitis, strokes and vascular thrombosis. Thus, the pathophysiology of this disease is related to an inflammatory process.

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Elcin, Huseyn. "EARLY IDENTIFICATION OF THE NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS". In International Trends in Science and Technology. RS Global Sp. z O.O., 2021. http://dx.doi.org/10.31435/rsglobal_conf/30032021/7474.

Texto completo da fonte

Resumo:

Diabetes mellitus is still a very common disease in the world and affects the daily lives of patients negatively. Diabetes is also known to be associated with neurological diseases such as peripheral nerve diseases, stroke and dementia. Among these, the most common disease is a peripheral nerve disease, and it has been reported that poor diabetic control increases the risk of development and can be prevented by education of the patients. Vascular dementia is more common in patients with diabetes than Alzheimer's disease, and it is thought that cerebrovascular diseases may berelated to cognitive impairment in diabetes. Although the mechanisms by which diabetes affects the brain are not clearly revealed, it is thought that changes in vascular structure, insulin resistance, glucose toxicity, oxidative stress, accumulation of glycation end products, hypoglycemic episodes and amyloid metabolism are effective.The aim of this article is to describe the neurological complications of diabetes and to emphasize the importance of patient education, good diabetes control and early diagnosis in preventing these complications.

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Maia, Jade Menezes, e Karine Gomes Bandeira Desteffani. "Main neurological changes in patients infected with Covid- 19: literature review". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.067.

Texto completo da fonte

Resumo:

Background: The world is experiencing a pandemic caused by COVID-19, which has already led to the death of 3.5 million individuals. In this context, the scientific community has made several discoveries, above all, that COVID-19 can promote other disorders, in addition to respiratory, such as the impairment of the nervous system. Objectives: To analyze the main neurological changes resulting from the infection by COVID-19. Design and setting: Cross-sectional observational study. Methods: Literature review with articles published in 2020, in journals indexed in the PubMed and Scielo databases, using the descriptors “Neurologic Manifestations” AND “covid-19, including articles in Portuguese and English. Results: Neurological symptoms have become increasingly recurrent in patients with COVID-19. SARS-CoV-2 reaches the Central Nervous System (CNS) through hematogenous or retrograde neuronal dissemination. Peripheral neuropathies and cerebrovascular events are associated with the severity of the disease. The elevation of D-dimer in critically ill patients triggers cerebrovasculares events, especially the development of ischemic stroke (stroke), which becomes more evident due to its risk factors. Changes in mental status are not limited to severe cases, and can occur at any stage of the disease, especially neuropsychiatric syndromes, such as anxiety, depression and post- traumatic stress. Conclusion: COVID-19, in an advanced stage, promotes peripheral neuropathies and cerebrovascular events. Furthermore, regardless of the severity stage, it can lead to changes in mental status.

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Díaz-Villamarín, X., CL Dávila-Fajardo, D. Blánquez-Martínez, E. Fernández-Gómez, A. Antúnez-Rodríguez e ÁS Raquel. "5PSQ-009 CYP2C19 SNP’sinfluence on clopidogrel response in cerebrovascular disease patients: final results". In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.442.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Castro, Kaline dos Santos Kishishita, Amanda Alves Cardoso da Silva, Ana Clara Mota Gonçalo, Camila Ângelo Vidal de Figueiredo, Lorena Menegussi Machado, Mariana Soares e Mylena Andréa Oliveira Torres. "SARS-CoV-2 and neurology: characteristics of patients with Covid-19 affected by CVA". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.085.

Texto completo da fonte

Resumo:

Introduction: Since the beginning of the pandemic in December 2019, COVID-19 caused by the infection of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in addition to the clinical manifestations already, can develop changes in the rate of blood clotting, where there are already notifications of Cerebrovascular Accident (CVA) associated with the virus. Objective: To know the characteristics of patients with COVID-19 affected by CVA, documented in the scientific literature. Method: A systematic literature review was carried out, using the MeSH Brower platform descriptors, namely: Stroke and Coronavirus, with an AND expression. The articles were searched in scientific databases: PubMed, MEDLINE Complete and SCIELO. 217 studies were found, of which 04 publications were included in this research. Results: Parallel studies on patient characteristics: elderly, male and comorbidities, such as hypertension, diabetes, heart disease and obesity, all risk factors for stroke. However, there were cases of young patients affected by CVA after the diagnosis of COVID-19. With regard to neurological changes, the researched articles state that most patients have symptoms such as deviation of the labial commissure on the right, dysarthria, aphasia, hemiplegia and hemianesthesia on the left. Conclusion: Although this incidence is not known, CVA is emerging as a complication of the COVID-19 pandemic. In this sense, further studies on the subject are necessary, since the elucidation of thrombotic mechanisms in patients with COVID- 19 can generate complications to prevent complications such as Cerebrovascular Accident.

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Sousa, Letícia Alves de, Luís Marcos Ferreira Junior, Lolrrayna Pedroso de Lima, Priscilla Rezende Pereira Silva e Marcus Vinícius de Araújo Vieira. "Sneddon’s Syndrome: a case report". In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.159.

Texto completo da fonte

Resumo:

Context: Sneddon’s Syndrome is a small and medium caliber arteries vasculopathy, characterized by concomitant occurrence of cerebrovascular disease and livedo reticularis. It’s a rare disorder, more prevalent in women. In up to 80% of cases, positive antiphospholipid’s antibodies are found. Case report: A 28-year-old woman was admitted to Hospital das ClínicasUFTM on May 21th, 2020, referred under suspicion of stroke with ictus on May 19th, 2020. The exam revealed left hemiparesis, anomic afasia and livedo reticularis on her thighs and thorax. She denied having comorbidities or previous episodes of thromboembolism. She had taken combined oral contraceptive for eleven years, having changed medication a year ago. In the cranial angioresonance exam, acute ischemia was confirmed in addition to moderate microangiopathy and an area of encephalomalacia. In the etiological investigation, HEP-2 positive antibody (antinuclear factor in a fine dotted nuclear pattern) was detected. She was discharged with a prescription of 100 mg of acetylsalicylic acid daily, maintained as a form of secondary prophylaxis. Conclusions: The case illustrates the importance of a thorough physical examination and anamnesis in cerebrovascular disease patients, in order to get a accurate aetiological diagnosis of these diseases, enabling a more effective prognostic evaluation and secondary prophylaxis.

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Assunção, Darah Fontes da Silva, Bruno Pissolati Mattos Gonzaga, Gabriel Chung, Lohana Santana Almeida da Silva, Marcelle Sanjuan Ganem Prado, Paulo Henrique Maia de Freitas, Rônney Pinto Lopes, Rosa Maria Nascimento Marcusso, Tamara Melissa Zavadzki Albuquerque e Rubens José Gagliardi. "Risk assessment for obstructive sleep apnea in stroke patients: a cross-sectional study". In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.717.

Texto completo da fonte

Resumo:

Introduction: Stroke is the second most prevalent cause of death in the world and an important cause of disability in adults. Obstructive sleep apnea (OSA) is an independent risk factor for stroke and is associated with poor poststroke functional outcome if left untreated. Objectives and methods: In this cross-sectional study, we aimed to determine the prevalence of OSA in ambulatory stroke patients using the STOPBang (snoring, tiredness, observed apnea, blood pressure, body mass index, age, neck size, gender) questionnaire. Casuistic and results: A total of 149 patients completed the clinical assessment. Mean age was 57.47 years, 75 (50.34%) were men and 74 (49.66%) were female. Among the patients, 56.37% were smokers or former smokers, and mean body mass index was 27.01 kg/m2 . The median STOP-Bang score was 3 (interquartile range: 2–4). 69.12% were considered moderate to severe risk for OSA (STOP-Bang score ≥3). For the identification of OSA, the questionnaire demonstrated sensitivity of 83.5%, accuracy of 75.2% and specificity of 45.5%. Among the 84 patients who answered the question about the presence of previous OSA symptoms, 59.53% had a negative answer. Discussion: Approximately two out of three stroke patients were classified as moderate to high risk for OSA, reinforcing the need for screening for the disease in this population. In addition, almost 60% reported no symptoms prior to cerebrovascular disease. Finally, the high sensitivity in this study confirms the usefulness of the tool in screening patients for diagnosis and therapeutic intervention. Conclusion: New studies are needed to evaluate OSA prevention and treatment strategies, as this measure will help in the global clinical recovery of the patient after the stroke.

Estilos ABNT, Harvard, Vancouver, APA, etc.

Relatórios de organizações sobre o assunto "Cerebrovascular disease - Patients"

1

Roldán-González, Elizabeth, Carolina Robledo-Castro, Piedad Rocío Lerma-Castaño e María Luisa Hurtado-Otero. Validity and reliability of the Wolf Motor Function Test -WMFT in patients with Cerebrovascular disease: Scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, outubro de 2022. http://dx.doi.org/10.37766/inplasy2022.10.0044.

Texto completo da fonte

Resumo:

Review question / Objective: This scoping review aimed to compile the studies that have examined the validity and reliability of the different versions of the Wolf Motor Function Test - WMFT in patients with Cerebrovascular disease. Background: Numerous investigations in rehabilitation have used the WMFT as an instrument for the primary measurement of the results; however, to date, there are no known reviews that have compiled the reliability and validity of the wolf test in its different versions, which is considered of vital importance and constitutes critical information for decision making in the process of evaluation and follow-up of patients with stroke in clinical, academic and research environments.

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Hu, XinYi, JingXuan Hao e HangYue Wang. Improvement of Environmental enrichment on Cognitive Functions in Patients and animals : A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, dezembro de 2022. http://dx.doi.org/10.37766/inplasy2022.12.0014.

Texto completo da fonte

Resumo:

Review question / Objective: To study the relationship between environmental enrichment and cognitive function through a meta-analysis of the literature, analyze its effects on the improvement of cognitive function in patients and animals, and evaluate the effects of different environmental enrichment measures on cognitive function improvement. Condition being studied: Cognitive decline refers to an individual's memory, language, reasoning and other aspects of cognitive function showing obvious, measurable decline or abnormal. The causes of cognitive decline are various, including neurodegeneration, cerebrovascular disease, infection, trauma, and depression. Alzheimer's disease and stroke are the most common.

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Zhang, Ruizhe, e Qingya Xie. A meta-analysis of cholesteryl ester transfer protein(CETP) gene rs708272(G>A) polymorphism in association with cornoary heart disease risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junho de 2023. http://dx.doi.org/10.37766/inplasy2023.6.0021.

Texto completo da fonte

Resumo:

Review question / Objective: To seek the association of the CETP rs708272 polymorphism with CHD.To figure out if the carriers of allele rs708272-A reduce or increase the risk of CHD in comparison with carriers of allele rs708272-G under allele model, dominant model and recessive model. Condition being studied: The inclusion criteria of CHD:(1)the presence of stenosis≥50% in a minimum of one main segment of coronary arteries (the right coronary artery, left circumfex, or left anterior descending arteries) by coronary angiography.(2) symptoms representing angina pectoris, electrocardiographic changes, and elevations of cardiac enzymes based on the criteria of the World Health Organization. (3) a certifed record of coronary artery bypass graft or percutaneous coronary intervention were included in the study.The exclusion criteria of CHD :patients with congenital heart disease, cardiomyopathy, and valvular disease.Controls:the same populations as the cases and specifed to be without CAD, cardiovascular and cerebrovascular diseases, and peripheral atherosclerotic arterial disease.

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

LI, Peng, e Junjun Liu. Effect of statin therapy on moderate-to-severe depression: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, março de 2022. http://dx.doi.org/10.37766/inplasy2022.3.0016.

Texto completo da fonte

Resumo:

Review question / Objective: We aim to assess the antidepressant effects of statin therapy among patients complicated with moderate to severe depression. Condition being studied: Depression is one of the major causes of disability worldwide, and major depressive disorders (MDD) contribute to a significant heavy disease burden, which is expected to be second by 2050, only to heart disease. Despite great improvement in therapy, the treatment efficacy remains low. Therefore, alternative therapies have been intensely investigated. A substantial body of researches have suggested that inflammation is one of the operative pathways between MDD and increased risk of somatic comorbidities, and some specific depressive symptoms. Depression occurs in most patients with cardiac and cerebrovascular disease due to the long-term effects, and depression increases the risk of cardiovascular disease in the population as a whole and in patients with coronary artery disease or stroke. Several observational studies have demonstrated reduced rates of depression among patients taking statins, which may be related to its anti-inflammatory effect. However, whether statin improves the depressive symptoms and its associated mechanism is still mixed. Furthermore, there is little evidence about statin treatment effect in those with moderate to severe depression. In addition, whether the effect of statin treatment on depressive symptom changes with time or is affected by baseline depression severity or percentage change of lipid levels has not been explored in previous studies.

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Chen, Sijia, Shuangyu Wang e lishuo Gao. Whether nurse-led telephone follow-up is more effective than usual care in improving blood pressure and LDL cholesterol levels in patients with cardiovascular and cerebrovascular disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, março de 2024. http://dx.doi.org/10.37766/inplasy2024.3.0054.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Li, Tian, Shanshan Jin, Wenhua Jiang, Nan Mu, Yishi Wang, Xiaokang Li, Yue Yin et al. Metformin may reduce the mortality and cardiac events in patients with cardio-cerebrovascular diseases, irrespective of concurrent diabetes: a meta-analysis of randomized controlled trails and cohort studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, junho de 2020. http://dx.doi.org/10.37766/inplasy2020.6.0008.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!